Aripiprazole vs Pembrolizumab

## Aripiprazole vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Aripiprazole** and **Pembrolizumab**.

## Mechanism of Action

**Aripiprazole**: Partial agonist at D2 and 5-HT1A receptors.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Aripiprazole — 75 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Aripiprazole — C23H27Cl2N3O2; Pembrolizumab — N/A.

**Molecular Weight**: Aripiprazole — 448.3850 g/mol; Pembrolizumab — N/A.

**Type**: Aripiprazole — Small molecule; Pembrolizumab — Antibody.